Movement Alert｜Argenx SE Rises 3.02% in Regular Trading, Trading at $942.51

Market Focus07-02

On July 2, Argenx SE rose 3.02% in regular trading, trading at $942.51 USD/share, with Turnover of $48.7359 million.

Within the Biotechnology sector where Argenx SE belongs, the overall sector performance is strong. Among individual stocks, Moderna up 11.1%, Abivax S.A. up 9.04%, AbbVie up 1.5%, Vertex Pharmaceuticals up 3.46%, Propanc Biopharma up 42.36%.

Argenx SE is a commercial-stage global biopharmaceutical company. Its core product Vyvgart is used to treat severe autoimmune diseases, with approved indications including all-serotype generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy. The company is scheduled to report next quarterly earnings on July 23.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1120696267?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-02 22:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1120696267","market":"us","top_or_hot":-1,"title":"Movement Alert｜Argenx SE Rises 3.02% in Regular Trading, Trading at $942.51","media":"Market Focus","content":"<p><p>On July 2, Argenx SE rose 3.02% in regular trading, trading at $942.51 USD/share, with Turnover of $48.7359 million.</p><p>Within the Biotechnology sector where Argenx SE belongs, the overall sector performance is strong. Among individual stocks, Moderna up 11.1%, Abivax S.A. up 9.04%, AbbVie up 1.5%, Vertex Pharmaceuticals up 3.46%, Propanc Biopharma up 42.36%.</p><p>Argenx SE is a commercial-stage global biopharmaceutical company. Its core product Vyvgart is used to treat severe autoimmune diseases, with approved indications including all-serotype generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy. The company is scheduled to report next quarterly earnings on July 23.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Argenx SE Rises 3.02% in Regular Trading, Trading at $942.51</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Argenx SE Rises 3.02% in Regular Trading, Trading at $942.51\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-02 22:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 2, Argenx SE rose 3.02% in regular trading, trading at $942.51 USD/share, with Turnover of $48.7359 million.</p><p>Within the Biotechnology sector where Argenx SE belongs, the overall sector performance is strong. Among individual stocks, Moderna up 11.1%, Abivax S.A. up 9.04%, AbbVie up 1.5%, Vertex Pharmaceuticals up 3.46%, Propanc Biopharma up 42.36%.</p><p>Argenx SE is a commercial-stage global biopharmaceutical company. Its core product Vyvgart is used to treat severe autoimmune diseases, with approved indications including all-serotype generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy. The company is scheduled to report next quarterly earnings on July 23.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ARGX","symbol_name":"Argenx SE","start_time":0,"source_url":"","article_id":"1120696267","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1120696267","pubTimestamp":1783001265,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 2, Argenx SE rose 3.02% in regular trading, trading at $942.51 USD/share, with Turnover of $48.7359 million.Within the Biotechnology sector where Argenx SE belongs, the overall sector...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ARGX":"Argenx SE"},"translate_title":"走势提示|Argenx SE常规交易上涨3.02%，报942.51美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ARGX":1},"content_text":"On July 2, Argenx SE rose 3.02% in regular trading, trading at $942.51 USD/share, with Turnover of $48.7359 million.Within the Biotechnology sector where Argenx SE belongs, the overall sector performance is strong. Among individual stocks, Moderna up 11.1%, Abivax S.A. up 9.04%, AbbVie up 1.5%, Vertex Pharmaceuticals up 3.46%, Propanc Biopharma up 42.36%.Argenx SE is a commercial-stage global biopharmaceutical company. Its core product Vyvgart is used to treat severe autoimmune diseases, with approved indications including all-serotype generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy. The company is scheduled to report next quarterly earnings on July 23.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1120696267","isCrawlerRequest":true}